IOVAIOVANCE BIOTHERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of IOVANCE BIOTHERAPEUTICS, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA본 종목 | $4.6B#4 | — | 6.3x#3 | 17.6x#1 | 60.6%#3 | -5.1%#3 | -153.1%#1 | -53.1%#5 | — | — | 365.9%#1 | — |
| KYMR | $9.8B#1 | — | 6.5x#5 | 249.8x#3 | -16.7%#4 | 39.1%#2 | -891.1%#3 | 20.6%#1 | — | — | 130.3%#2 | — |
| PCVX | $8.7B#2 | — | 3.1x#2 | — | — | -65.2%#4 | — | -0.0%#2 | — | — | 78.5%#3 | — |
| CGON | $6.6B#3 | — | 6.4x#4 | 1639.6x#4 | 254.7%#1 | -82.9%#5 | -4722.1%#4 | -15.6%#4 | -18.8%#1 | — | — | — |
| BEAM | $2.6B#5 | — | 2.4x#1 | 18.4x#2 | 120.0%#2 | 78.8%#1 | -274.6%#2 | -7.5%#3 | -40.5%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-19.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice